中文摘要
本論文以 ethyl L-lactate 作為起始物，經由多步驟反應，分別合成 Z 型和 E 型烯類化合物 (6 E、16 Z、24 Z)，再以此烯類化合物生成4-甲基-3-氧-1-氮二環[3.1.0]己烷-2-酮 (4-methyl-3-oxa-1-azabicyclo[3.1.0] hexan-2-one) (11、19、27)，再以4-甲基-3-氧-1-氮二環[3.1.0]己烷-2-酮與親核試劑，進行親核加成反應，形成單一鏡像化合物 (enantiopure compounds)，以建構具有掌性的四級碳中心。最後，將此策略應於合成ent-D-Kijanose 31 a/b。由於 D-Kijanose 為一具有支鏈的特殊硝基醣 (nitrosuga)，而該硝基醣與已知具有生物活性的 kijanimicin 結合後，將擁有良好的抗腫瘤性和抗生素的活性，因此合成 ent-Kijanoside 為本論文致力研究的目標產物。
關鍵字：吖環丙烷，掌性四級碳中心，非鏡像選擇性，ent-Kijanoside

Abstract
In this paper, ethyl L-lactate was used as a starting material to synthesize Z-type and E-type alkenes (6 E、16 Z、24 Z) through a multi-step reaction, respectively. The compounds synthesize 4-methyl-3-oxa-1-azabicyclo[3.1.0] hexan-2-one (11、19、27), followed by a 4-methyl-3-oxa-1-azabicyclo[3.1.0] hexan-2-one is subjected to a nucleophilic addition reaction with a nucleophile to form a single diastereoisomer to construct a chiral quaternary carbon center. Finally, the method of constructing a chiral quaternary carbon center was applied to ent-D-Kijanose's synthesis strategy. Since D-Kijanose is a branched nitrosuga, which connects with the biologically active Kijanimicin, it has antitumor and antibiotic activity.Therefore, the synthesis of ent-Kijanoside is the target product of this paper.
Keywords: aziridine, chiral quaternary carbon center, diastereoselectivity, ent-Kijanoside.

第五章 相關文獻
(1) Mallams, A. K.; Puar, M. S.; Rossman, R. R. J. Am. Chem. Soc. 1981, 103, 3938.
(2) (a) Anether, G.; Tinhofer, I.; Senfter, M.; Greil, R. Blood. 2003, 101, 4561-4568. (b) Hara, T.; Omura-Minamisawa, M. C.; Cheng; Nakagami, Y.; Ito, M.; Inoue. T. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61, 517-528. (c)Nakashima, T.; Miura, M.; Hara, M. Cancer Res. 2000, 60, 1229-1235. (d) Tinhofer, I.; Anether, G.; Senfter, M.; Pfaller, K.; Bernhardt, D.; Hara, M.; Greil, R. FASEB J. 2002, 16, 1295-1297. (e) Kaneko, M.; Nakashima, T.; Uosaki, Y.; Hara, M.; Ikeda, S.; Kanda, Y. Bioorg. Med. Chem. Lett. 2001, 11, 887-890.
(3) (a)Yoshii, E.; Funaki, K.; Takeda, K. Tetrahedron Lett. 1982, 23, 3069-3072. (b) Yoshii, E.; Funaki, K.; Takeda, K. Chem. Pharm. Bull. 1982, 30, 4031-4036.
(4) Giuliano, R. M.; Deisenroth, T. W., J. Carbohy. Chem. 1987, 6, 295-299.
(5) Holden, H. M.; Garrett, T. D.; Thoden, J. B. J. Am. Chem. Soc. 2007, 129, 14670-14683.
(6) (a) Tanner, D. Pure Appl. Chem. 1993, 65, 1319. (b) Tanner, D. Angew. Chem. Int. Ed. Engl. 1994, 33, 599. (c) McCoull, W.; Davis, F. A. Synthesis. 2000, 1347. (d) Sweeney, J. B. Chem. Soc. ReV. 2002, 31, 247. (e) Dahanukar, V. H.; Zavialov, L. A. Curr. Opin. Drug DiscoVery DeV. 2002, 5, 918. (f) Lee, W. K.; Ha, H.-J. Aldrichimica Acta. 2003, 36, 57. (g) Padwa, A.; Murphree, S. S. ARKIVOC. 2006, 6.
(7) (a) Maligres, P. E.; See, M. M.; Askin, D.; Reider, P. J. Tetrahedron Lett. 1997, 38, 5253. (b) Lin, P.-y.; Bellos, K.; Stamm, H.; Onistschenko, A. Tetrahedron 1992, 48, 2359. (c) Sureshkumar, D.; Gunasundari, T.; Ganesh, V.; Chandrasekaran, S. J. Org. Chem. 2007, 72, 2106.
(8) (a) McCoull, W.; Davis, F. A. Synthesis. 2000, 1347. (b) Sweeney, J. B. Chem. Soc. ReV. 2002, 31, 247. (c) Chemla, F.; Ferreira, F. Curr. Org. Chem. 2002, 6, 539.
(9) (a) Keller-Schierlein, W.; Muntwyler, R.; Pache, W.; Zaehner, H. HelV. Chim.Acta. 1969, 52, 127-142. (b) Ohtsuka, T.; Kotaki, H.; Nakayama, N.; Itezono, Y.; Shimma, N.; Kudoh, T.; Kuwahara, T.; Arisawa, M.; Yokose, K. J. Antibiot. 1993, 46, 11-17. (c) Takeuchi, T.; Hamada, M.; Osanawa, H.; Takahashi, Y.; Sawa, R. Jpn. Kokai Tokkyo Koho JP-1994332226, 1996. (d) Bonjouklian, R.; Mynderse, J. S.; Hunt, A. H.; Deeter, J. B. Tetrahedron. Lett. 1993, 34, 7857-7860. (e) Yamamoto, K.; Hayakawa, Y. Jpn. Kokai Tokkyo Koho JP-198737314, 1988. (f) Matsumoto, M.; Kawamura, Y.; Yoshimura, Y.; Terui, Y.; Nakai, H.; Yoshida, T.; Shoji, J. J. Antibiot. 1990, 43, 739-747. (g) Furumai, T.; Takagi, K.; Igarashi, Y.; Saito, N.; Oki, T. J. Antibiot. 2000, 53, 227-232. (h) Shimotohno, K. W.; Endo, T.; Furihata, K. J. Antibiot. 1993, 46, 682-684. (i) Tomita, F.; Tamaoki, T. J. Antibiot. 1980, 33, 940-945. (j) Ashton, R. J.; Kenig, M. D.; Luk, K.; Planterose, D. N.; Scott-Wood, G. J. Antibiot. 1990, 43, 1387-1393. (k) Tanaka, T.; Komaki, H.; Nemoto, A.; Yasawa, K.; Mikami, J. Jpn. Kokai Tokkyo Koho JP-200056538, 2001. (l) Horan, A. C.; Shearer, M. C.; Hegde, V.; Beyazova, M. L.; Brodsky, B. C.; King, A.; Berrie, R.; Cardaci, K.; Nimeck, M. J. Antibiot. 1997, 50,119-125.
(10) Hu, X. E. Tetrahedron. 2004, 60, 2701.。
(11) Joullie. M. M; Pixu, L.; Evans, C. D. Org. Lett. 2005, 7, 5326-5327.
(12) (a) Joullie´M.M.; Erin M. ; Evans, C. D.; Gilleran, J. A.; Pixu Li , J.Am.Chem.Soc. 2007, 129, 14463-14469. (b) Joullié, M. M.; Kelley, B. T.; Tetrahedron, 2013, 24, 1233. (c) Brandon T. Kelley, Patrick Carroll. Org. Chem. 2014, 79, 5121−5133. (d) Joullie´. M. M.; Kelley, B.T. Org. Lett. 2010, 12, 4244-4247.
(13) Hou, D. R.; Chang, Y. J; Hsuan, Y. C; Lai, A. C. Y.; Han, Y-C. Org. Lett. 2016, 18, 808−811
(14) Matsukawa, Y.; Isobe, M.; Kotsuki, H.; Ichikawa, Y. J. Org. Chem. 2005, 70, 5339-5341
(15) Nishikawa, T.; Yamada, H; Adachi, M. Chem. Commun. 2013, 49, 11221-11223.
(16) Ming, C. C.; Deng , Q. H.; Wang, J. C.; Jiang, X. Z.; Zhou, C.Y. Synthesis, 2011, 18, 2959 -2967.
(17) Marshall, J. A.; Yanik, M.M.; Adams, N.D.; Ellis, K.C.; Chobanian, H. R. Organic Syntheses. 2005, 81, 157-170.
(18) Jun, H. T.; Shijun, Z.; Wei, L. X.; Yikang W; Li. Y. Eur. J. Org. Chem.2015, 3, 647–654.
(19) (a) Bergmeier, S. C.; Stanchina, D. M. J. Org. Chem. 1999, 64, 2852-2859. (b) Bergmeier, S. C.; Katz, S. J. J. Comb. Chem. 2002, 4, 162-166.
(20) Tsuzaki, S; Usui, S; Oishi, H; Yasushima, H; Fukuyasu, T; Oishi, T; Sato, T; Chida, N. Org. Lett. 2015, 177, 1704-1707.
(21) Mathieu, F.C.; Proust, N; Lauer, M. G.; Stambuli. J. P. Org. Lett. 2011, 12, 3246-3249.
(22) Mithran, S.; Subbaraman, A. S. Molecules, 1999, 4, 159-164.